Abstract
Alzheimer’s disease is an age-related neurodegenerative disease, associated with the presence of extracellular amyloid-β (Aβ) plaques and neurofibrillary tangles. Although the pathogenesis of AD remains unclear, the characteristic feature of AD was reported to be the buildup of Aβ plaques. In this study, we extensively investigated the neuroprotective effects of 2-substituted 1,3-selenazole amide derivatives (CHF11) on Aβ1-42 transgenic Caenorhabditis elegans CL4176. Results showed that worms fed with CHF11 exhibited remarkably reduced paralysis, decreased levels of toxic Aβ oligomers and Aβ plaque deposition, as well as less ROS production in comparison with the untreated worms. The effective concentrations of CHF11 were arranged in the descending order of 100 µM > 10 µM > 1 µM. Real-time PCR analysis showed that there was no significant difference in Aβ expression between CHF11-administered group and the blank control group, suggesting that CHF11-induced reduction in toxic protein deposition may be regulated at the post-transcriptional level. In the meantime, the gene expressions of hsf-1 and its downstream target hsp-12.6 were significantly increased, indicating that CHF11 against Aβ toxicity may involve in HSF-1 signaling pathway in worms. In conclusion, CHF11 exhibits a significant protective effect against β-amyloid-induced toxicity in CL4176 by reducing β-amyloid aggregation and ROS production, which may involve in HSF-1 and downstream target HSP-12.6 pathway.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alexander AG, MarfilLI C. V (2014) Use of C. elegans as a model to study Alzheimer’s disease and other neurodegenerative disease. Front Genet 5:1–21. https://doi.org/10.3389/fgene.2014.00279
Bondi MW, Edmonds EC, Salmon DP (2017) Alzheimer’s disease: past, present, and future. J Int Neuropsychol Soc 23:818–831. https://doi.org/10.1017/S135561771700100X
Borgegard T, Gustavsson S, Nilsson C, Parpal S, Klintenberg R, Berg AL, Rosqvist S, Serneels L, Svensson S, Olsson F, Jin S, Yan H, Wanngren J, Jureus A, Ridderstad-Wollberg A, Wollberg P, Stockling K, Karlstrom H, Malmberg A, Lund J, Arvidsson PI, de Strooper B, Lendahl U, Lundkvist J (2012) Alzheimer’s disease: presenilin 2-sparing gamma-secretase inhibition is a tolerable Abeta peptide-lowering strategy. J Neurosci 32:17297–17305. https://doi.org/10.1523/JNEUROSCI.1451-12.2012
Butterfield DA (1997) beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer’s disease. Chem Res Toxicol 10:495–506. https://doi.org/10.1021/tx960130e
Calderwood SK, Murshid A (2017) Molecular chaperone accumulation in cancer and decrease in Alzheimer’s disease: the potential roles of HSF1. Front Neurosci 11:192. https://doi.org/10.3389/fnins.2017.00192
Contestabile A (2011) The history of the cholinergic hypothesis. Behav Brain Res 221:334–340. https://doi.org/10.1016/j.bbr.2009.12.044
de Jong WW, Caspers GJ, Leunissen JA (1998) Genealogy of the alpha-crystallin–small heat-shock protein superfamily. Int J Biol Macromol 22:151–162. https://doi.org/10.1016/s0141-8130(98)00013-0
Dickson DW (1997) Neuropathological diagnosis of Alzheimer’s disease: a perspective from longitudinal clinicopathological studies. Neurobiol Aging 18:S21–S26. https://doi.org/10.1016/S0197-4580(97)00065-1
Diomede L, Rigacci S, Romeo M, Stefani M, Salmona M (2013) Oleuropein aglycone protects transgenic C. elegans strains expressing Abeta42 by reducing plaque load and motor deficit. PLoS One 8:e58893. https://doi.org/10.1371/journal.pone.0058893
Drake J, Link CD, Butterfield DA (2003) Oxidative stress precedes fibrillar deposition of Alzheimer’s disease amyloid beta-peptide (1–42) in a transgenic Caenorhabditis elegans model. Neurobiol Aging 24:415–420. https://doi.org/10.1016/S0197-4580(02)00225-7
Du F, Zhou L, Jiao Y, Bai S, Wang L, Ma J, Fu X (2019). Ingredients in Zijuan Pu'er Tea Extract Alleviate beta-Amyloid Peptide Toxicity in a Caenorhabditis elegans Model of Alzheimer's Disease Likely through DAF-16. Molecules 24. https://doi.org/10.3390/molecules24040729
Dumont M, Wille E, Stack C, Calingasan NY, Beal MF, Lin MT (2009) Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer’s disease. FASEB J 23:2459–2466. https://doi.org/10.1096/fj.09-132928
Edwards HV, Cameron RT, Baillie GS (2011) The emerging role of HSP20 as a multifunctional protective agent. Cell Signal 23:1447–1454. https://doi.org/10.1016/j.cellsig.2011.05.009
Fei T, Fei J, Huang F, Xie T, Xu J, Zhou Y, Yang P (2017) The anti-aging and anti-oxidation effects of tea water extract in Caenorhabditis elegans. Exp Gerontol 97:89–96. https://doi.org/10.1016/j.exger.2017.07.015
Folch J, Petrov D, Ettcheto M, Abad S, Sanchez-Lopez E, Garcia ML, Olloquequi J, Beas-Zarate C, Auladell C, Camins A (2016) Current research therapeutic strategies for Alzheimer’s disease treatment. Neural Plast 2016:8501693. https://doi.org/10.1155/2016/8501693
Furukawa-Hibi Y, Kobayashi Y, Chen C, Motoyama N (2005) FOXO transcription factors in cell-cycle regulation and the response to oxidative stress. Antioxid Redox Signal 7:752–760. https://doi.org/10.1111/j.1475-4959.2010.00371.x
Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer’s disease. Trends Pharmacol Sci 12:383–388. https://doi.org/10.1016/0165-6147(91)90609-v
Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256:184–185. https://doi.org/10.1126/science.1566067
Hashimoto M, Rockenstein E, Crews L, Masliah E (2003) Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer’s and Parkinson’s diseases. Neuromolecular Med 4:21–36. https://doi.org/10.1385/NMM:4:1-2:21
Hsu AL, Murphy CT, Kenyon C (2003) Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science 300:1142–1145. https://doi.org/10.1126/science.1083701
Jash K, Gondaliya P, Kirave P, Kulkarni B, Sunkaria A, Kalia K (2019) Cognitive dysfunction: a growing link between diabetes and Alzheimer’s disease. Drug Dev Res. https://doi.org/10.1002/ddr.21579
Kampkotter A, Pielarski T, Rohrig R, Timpel C, Chovolou Y, Watjen W, Kahl R (2007) The Ginkgo biloba extract EGb761 reduces stress sensitivity, ROS accumulation and expression of catalase and glutathione S-transferase 4 in Caenorhabditis elegans. Pharmacol Res 55:139–147. https://doi.org/10.1016/j.phrs.2006.11.006
Karpov AS, Amiri P, Bellamacina C, Bellance MH, Breitenstein W, Daniel D, Denay R, Fabbro D, Fernandez C, Galuba I, Guerro-Lagasse S, Gutmann S, Hinh L, Jahnke W, Klopp J, Lai A, Lindvall MK, Ma S, Mobitz H, Pecchi S, Rummel G, Shoemaker K, Trappe J, Voliva C, Cowan-Jacob SW, Marzinzik AL (2015) Optimization of a dibenzodiazepine hit to a potent and selective allosteric PAK1 inhibitor. ACS Med Chem Lett 6:776–781. https://doi.org/10.1021/acsmedchemlett.5b00102
Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R (1993) A C. elegans mutant that lives twice as long as wild type. Nature 366:461–464. https://doi.org/10.1038/366461a0
Kotlar I, Colonnello A, Aguilera-Gonzalez MF, Avila DS, de Lima ME, Garcia-Contreras R, Ortiz-Plata A, Soares FAA, Aschner M, Santamaria A (2018) Comparison of the toxic effects of quinolinic acid and 3-nitropropionic acid in C. elegans: involvement of the SKN-1 pathway. Neurotox Res 33:259–267. https://doi.org/10.1007/s12640-017-9794-x
Kumar J, Park KC, Awasthi A, Prasad B (2015) Silymarin extends lifespan and reduces proteotoxicity in C. elegans Alzheimer’s model. CNS Neurol Disord Drug Targets 14:295–302. https://doi.org/10.2174/1871527314666150116110212
Kurz A, Perneczky R (2011) Amyloid clearance as a treatment target against Alzheimer’s disease. J Alzheimers Dis 24(Suppl 2):61–73. https://doi.org/10.3233/JAD-2011-102139
Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, Destafano AL, Bis, JC, Beecham GW, Grenier-Boley B, Russo G, Thorton-wells TA, Jones N, Smith AV, Chouraki V, Thomas C, Ikram MA, Zelenika D, Vardarajan BN, Kamatani Y, Lin CF, Gerrish A, Schmidt H, Kunkle B, Dunstan ML, Ruiz A, Bihoreau MT, Choi SH, Reitz C, Pasquier F, Cruchaga C, Craig D, Amin N, Berr C, Lopez OL, De Jager PL, Deramecourt V, Johnston JA, Evans D, Lovestone S, Letenneur L, Moron FJ. Rubinsztein DC, Eiriksdottir G, Sleegers K, Goate AM, Fievet N, Huentelman MW, Gill M, Brown K, Kamboh MI, Keller L, Barberger-Gateau P, Mcguiness B, Larson EB, Green R, Myers AJ, Dufouil C, Todd S, Wallon D, Love S, Rogaeva E, Gallacher J, St George-Hyslop P, Clarimon J, Lleo A, Bayer A, Tsuang DW, Yu L, Tsolaki M, Bossu P, Spalletta G, Proitsi P, Collinge J, Sorbi S, Sanchez-Garcia F, Fox NC, Hardy J, Deniz Naranjo MC, Bosco P, Clarke R, Brayne C, Galimberti D, Mancuso M, Matthews F, European Alzheimer's Disease I, Genetic Environmental Risk in Alzheimer's D, Alzheimer's Disease Genetic C, Cohorts for H, Aging Research in Genomic E, Moebus S, Mecocci P, Del Zompo M, Maier W, Hampel H, Pilotto A, Bullido M, Panza F, Caffarra P, et al. (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease Nat Genet 2013/10/29 ed. https://doi.org/10.1038/ng.2802
Lee J, Kim DE, Griffin P, Sheehan PW, Kim DH, Musiek ES, Yoon SY (2020) Inhibition of REV-ERBs stimulates microglial amyloid-beta clearance and reduces amyloid plaque deposition in the 5XFAD mouse model of Alzheimer’s disease. Aging Cell 19:e13078. https://doi.org/10.1111/acel.13078
Li X, Matilainen O, Jin C, Glover-Cutter KM, Holmberg CI, Blackwell TK (2011) Specific SKN-1/Nrf stress responses to perturbations in translation elongation and proteasome activity. PLoS Genet 7:e1002119. https://doi.org/10.1371/journal.pgen.1002119
Link CD (1995) Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci U S A 92:9368–9372. https://doi.org/10.1073/pnas.92.20.9368
Link CD (2006) C. Elegans Models of Age-associated Neurodegenerative Diseases: Lessons from transgenic worm models of Alzheimer’s disease Elsevier Inc. https://doi.org/10.1016/j.exger.2006.06.059
Lublin AL, Link CD (2013) Alzheimer’s disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for beta-amyloid peptide-induced toxicity. Drug Discov Today Technol 10:e115–e119. https://doi.org/10.1016/j.ddtec.2012.02.002
Luo Y, Zhang J, Liu N, Luo Y, Zhao B (2011) Copper ions influence the toxicity of beta-amyloid(1–42) in a concentration-dependent manner in a Caenorhabditis elegans model of Alzheimer’s disease. Sci China Life Sci 54:527–534. https://doi.org/10.1007/s11427-011-4180-z
Maiti P, Manna J, Veleri S, Frautschy S (2014) Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin. Biomed Res Int 2014:495091. https://doi.org/10.1155/2014/495091
Ou JR, Tan MS, Xie AM, Yu JT, Tan L (2014) Heat shock protein 90 in Alzheimer’s disease. Biomed Res Int 2014:796869. https://doi.org/10.1155/2014/796869
Rea SL, Wu D, Cypser JR, Vaupel JW, Johnson TE (2005) A stress-sensitive reporter predicts longevity in isogenic populations of Caenorhabditis elegans. Nat Genet 37:894–898. https://doi.org/10.1038/ng1608
Roberds SL, Anderson J, Basi G, Bienkowski MJ, Branstetter DG, Chen KS, Freedman SB, Frigon NL, Games D, Hu K, Johnson-Wood K, Kappenman KE, Kawabe TT, Kola I, Kuehn R, Lee M, Liu W, Motter R, Nichols NF, Power M, Robertson DW, Schenk D, Schoor M, Shopp GM, Shuck ME, Sinha S, Svensson KA, Tatsuno G, Tintrup H, Wijsman J, Wright S, McConlogue L (2001) BACE knockout mice are healthy despite lacking the primary β-secretase activity in brain: implications for Alzheimer’s disease therapeutics. Hum mol genet 10:1317–1324. https://doi.org/10.1093/hmg/10.12.1317
Seki T, Kanaga M, Kobayashi K, Kowa H, Yahata N, Maruyama K, Iwata N, Inoue H, Toda T (2020) Galectin 3-binding protein suppresses amyloid-β production by modulating β-cleavage of amyloid precursor protein. J Biol Chem 295:3678–3691. https://doi.org/10.1074/jbc.RA119.008703
Sevigny J, Chiao P, Bussiere T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O’Gorman J, Qian F, Arastu M, Li M, Chollate S, Brennan MS, Quintero-Monzon O, Scannevin RH, Arnold HM, Engber T, Rhodes K, Ferrero J, Hang Y, Mikulskis A, Grimm J, Hock C, Nitsch RM, Sandrock A (2016) The antibody aducanumab reduces Abeta plaques in Alzheimer’s disease. Nature 537:50–56. https://doi.org/10.1038/nature19323
Shanmuganathan B, Sathya S, Balasubramaniam B, Balamurugan K, Devi KP (2019) Amyloid-beta induced neuropathological actions are suppressed by Padina gymnospora (Phaeophyceae) and its active constituent alpha-bisabolol in Neuro2a cells and transgenic Caenorhabditis elegans Alzheimer’s model. Nitric Oxide 91:52–66. https://doi.org/10.1016/j.niox.2019.07.009
Sonani RR, Rastogi RP, Singh NK, Thadani J, Patel PJ, Kumar J, Tiwari AK, Devkar RV, Madamwar D (2017) Phycoerythrin averts intracellular ROS generation and physiological functional decline in eukaryotes under oxidative stress. Protoplasma 254:849–862. https://doi.org/10.1007/s00709-016-0996-5
Trojanowski JQ, Mattson MP (2003) Overview of protein aggregation in single, double, and triple neurodegenerative brain amyloidoses. Neuromolecular Med 4:1–6. https://doi.org/10.1385/NMM:4:1-2:1
van der Kant R, Goldstein LSB, Ossenkoppele R (2020) Amyloid-beta-independent regulators of tau pathology in Alzheimer disease. Nat Rev Neurosci 21:21–35. https://doi.org/10.1038/s41583-019-0240-3
Walker GA, Lithgow GJ (2003) Lifespan extension in C. elegans by a molecular chaperone dependent upon insulin-like signals. Aging Cell 2:131–139. https://doi.org/10.1046/j.1474-9728.2003.00045.x
Yang J, Huang XB, Wan QL, Ding AJ, Yang ZL, Qiu MH, Sun HY, Qi SH, Luo HR (2017) Otophylloside B protects against abeta toxicity in Caenorhabditis elegans models of Alzheimer’s disease. Nat Prod Bioprospect 7:207–214. https://doi.org/10.1007/s13659-017-0122-1
Yang ZZ, Yu YT, Lin HR, Liao DC, Cui XH, Wang HB (2018) Lonicera japonica extends lifespan and healthspan in Caenorhabditis elegans. Free Radic Biol Med 129:310–322. https://doi.org/10.1016/j.freeradbiomed.2018.09.035
Zhang J, Shi R, Li H, Xiang Y, Xiao L, Hu M, Ma F, Ma CW, Huang Z (2016) Antioxidant and neuroprotective effects of Dictyophora indusiata polysaccharide in Caenorhabditis elegans. J Ethnopharmacol 192:413–422. https://doi.org/10.1016/j.jep.2016.09.031
Zhang Z, Shen Q, Wu X, Zhang D, Xing D (2020) Activation of PKA/SIRI1 signaling pathway by photobiomodulation therapy reduces Aβ levels in Alzheimer’s disease models. Aging Cell 19:1–15. https://doi.org/10.1111/acel.13054
Zhu S, Li H, Dong J, Yang W, Liu T, Wang Y, Wang X, Wang M, Zhi D (2017) Rose essential oil delayed Alzheimer’s disease-like symptoms by SKN-1 pathway in C. elegans. J Agric Food Chem 65:8855–8865. https://doi.org/10.1021/acs.jafc.7b03224
Zhu Z, Yang T, Zhang L, Liu L, Yin E, Zhang C, Guo Z, Xu C, Wang X (2019) Inhibiting Aβ toxicity in Alzheimer’s disease by a pyridine amine derivative. Eur J Med Chem 168:330–339. https://doi.org/10.1016/j.ejmech.2019.02.052
Acknowledgments
The authors thank Dr. Junhai Xiao for characterization CHF11 and Dr. Yin Gao for improving the quality of the manuscript’s writing.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wang, H., Yue, Y., Zhao, H. et al. Neuroprotective Effects of 2-Substituted 1, 3-Selenazole Amide Derivatives on Amyloid-Beta-Induced Toxicity in a Transgenic Caenorhabditis Elegans Model of Alzheimer’s Disease. Neurotox Res 39, 841–850 (2021). https://doi.org/10.1007/s12640-020-00321-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12640-020-00321-x